Patents by Inventor David Teachey

David Teachey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS COMPRISING ANTI-CD38 CHIMERIC ANTIGEN RECEPTORS (CARS)
    Publication number: 20250121004
    Abstract: The present invention provides compositions and methods comprising anti-CD38 chimeric antigen receptors (CARs). Compositions and methods of treatment are also provided.
    Type: Application
    Filed: January 24, 2023
    Publication date: April 17, 2025
    Inventors: Saar GILL, Richard APLENC, Tina GLISOVIC-APLENC, David TEACHEY
  • BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
    Publication number: 20240288444
    Abstract: The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).
    Type: Application
    Filed: July 12, 2023
    Publication date: August 29, 2024
    Inventors: Alfred Garfall, Alex Ganetsky, Saar Gill, Simon Lacey, Jan J. Melenhorst, David Teachey, Eric Lancaster, Adam David Cohen, Pamela Shaw
  • Biomarkers predictive of cytokine release syndrome
    Patent number: 11747346
    Abstract: The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: September 5, 2023
    Assignees: Novartis AG, The Trustees of the University of Pennsylvania
    Inventors: Alfred Garfall, Alex Ganetsky, Saar Gill, Simon Lacey, Jan J. Melenhorst, David Teachey, Eric Lancaster, Adam David Cohen, Pamela Shaw
  • BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
    Publication number: 20180252727
    Abstract: The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).
    Type: Application
    Filed: September 2, 2016
    Publication date: September 6, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Alfred Garfall, Alex Ganetsky, Saar Gill, Simon Lacey, Jan J. Melenhorst, David Teachey